Form 4 for CRSP CRISPR Therapeutics AG
Accepted 2024-03-18 00:00:00 ET · period of report 2024-03-14 · accession 0000950170-24-032990 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-03-18 | 2024-03-14 | CRSP | Prasad Raju | CFO | M - OptEx | — | +10.0K | 10.0K | New | — |
| D | 2024-03-18 | 2024-03-15 | CRSP | Prasad Raju | CFO | S - Sale+OE | $72.69 | -3,524 | 6,476 | -35% | -$256.2K |
| D | 2024-03-18 | 2024-03-14 | CRSP | Prasad Raju | CFO | M - OptEx | — | -10.0K | 30.0K | -25% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2024-03-14 | M | A | 10,000 | — | 10,000 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. |
| 2 | Common | Common Shares | 2024-03-15 | S | D | 3,524 | $72.69 | 6,476 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2024-03-14 | M | D | 10,000 | — | 30,000 | D | — · — to — | 10,000 Common Shares | (F1) Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. (F3) This restricted stock unit award was granted on March 14, 2023 with respect to 40,000 Common Shares, with (i) one quarter of the shares vesting on March 14, 2024, (ii) one quarter of the shares vesting on March 14, 2025, (iii) one quarter of the shares vesting on March 14, 2026, and (iv) one quarter of the shares vesting on March 14, 2027. |